Sugi Predict

Sugi Predict / Compounds / SCHEMBL10207243

SCHEMBL10207243

SCHEMBL10207243

CCC(CCCCB1OC(C)(C)C(C)(C)O1)(CN1CCCCC1)NC(=O)OCc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 4/20 0.36
▸ FKBP1A P62942 4/20 0.35
▸ ITGB3 P05106 2/20 0.35
▸ ITGA2B P08514 2/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CTSL P07711 3/20 0.33
▸ CTSB P07858 2/20 0.33
▸ CTSK P43235 1/20 0.33
▸ CTSS P25774 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPY1R P25929 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL895100 0.86 MEN1 (0.37) OPRK1FKBP1AITGB3ITGA2BMEN1
SCHEMBL12292155 0.83 FKBP1A (0.34) OPRK1FKBP1AITGB3ITGA2BMEN1
SCHEMBL19764741 0.77 MEN1 (0.40) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL10266056 0.76 MEN1 (0.40) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL10006168 0.74 MCHR1 (0.43) CTSKMCHR1
SCHEMBL894621 0.74 MEN1 (0.39) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL12506419 0.73 MEN1 (0.38) ITGB3ITGA2BMEN1KMT2AALDH1A1
SCHEMBL10265690 0.73 MEN1 (0.38) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL895661 0.73 KMT2A (0.39) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL17896127 0.73 MEN1 (0.39) MEN1KMT2AALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9994594-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2018-06-12 — — US disclosed
US-20170183362-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2017-06-29 — — US disclosed
US-9040703-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2015-05-26 — — US disclosed
US-20140371175-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2014-12-18 — — US disclosed
US-20120083469-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2012-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170183362-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT9 OPRK1 1851/4885FKBP1A 3416/4885ITGB3 4229/4885
US-20120083469-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT9 OPRK1 1851/4885FKBP1A 3416/4885ITGB3 4229/4885
US-20140371175-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT9 OPRK1 1851/4885FKBP1A 3416/4885ITGB3 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.